Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SUPREME COURT SEEKS ADMINISTRATION'S OPINION ON IDE APPROVAL PREEMPTION OVER TORT CLAIMS; IOLAB PETITION QUESTIONS APPLICABILITY OF MEDTRONIC V. LOHR

This article was originally published in The Gray Sheet

Executive Summary

The Administration is expected to file in 60-90 days its opinion on whether FDA's Investigational Device Exemption regulation preempts state tort claims in response to a case before the U.S. Supreme Court.

You may also be interested in...



Supreme Court Seeks Solicitor General’s Input On PMA Preemption

The U.S. Supreme Court is considering whether to hear a potentially far-reaching case on whether patients injured by PMA-approved devices can sue manufacturers under state laws

‘Supplement’ On CBD Product Label A Bullseye For US Litigants, Says Attorney

Two CBD marketers warned by FDA in a recent crackdown are targeted in class action complaints alleging they made unsubstantiated health claims and mislabeled ‘illegal drug’ products as supplements. Complaints are a wake-up call to CBD wellness industry to ensure claims are substantiated, as the class action bar is on the prowl following the agency’s 15 warning letter blast in November.
UsernamePublicRestriction

Register

MT007974

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel